Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes

Zih An Chen, Si Han Wu, Peilin Chen, Yi Ping Chen, Chung Yuan Mou

研究成果: 雜誌貢獻文章

2 引文 (Scopus)

摘要

Mesoporous silica nanoparticles (MSNs) hold great potential as a versatile platform for biomedical applications, especially drug delivery. However, evidence shows that MSNs even when PEGylated are rapidly cleared from the bloodstream by the monocyte phagocytic system. Erythrocytes, also called red blood cells (RBCs), can serve as biocompatible carriers of various bioactive substances, including drugs, enzymes, and peptides. In this work, we synthesize a series of fluorescent PEGylated MSNs with different synthetic diameters ranging from 10 to 200 nm and investigate the size effect on their encapsulation in human RBCs (hRBCs) by a hypotonic dialysis-based method. According to fluorescence images and flow cytometry analyses, we demonstrated that a hydrodynamic diameter below 30 nm is critical for efficient MSN encapsulation. Confocal microscopy and scanning electron microscopy images further confirmed that PEGylated MSNs were successfully embedded inside RBC. PEGylation serves an important role not only for stabilizing MSNs in biological milieu but also for reducing significant hemolysis caused by bare MSNs and thus for successful encapsulation. In addition to PEGylation, we further introduce positively charged functional groups onto the MSNs to show that nanoparticle-encapsulated hRBCs could serve as depots for delivering biological molecules through electrostatic attraction or chemical conjugation with MSNs. Also, we verify the existence of CD47 membrane protein, a marker of self, on the nanoparticle-encapsulated hRBCs and assess its ability of circulation in the blood, which could act as a circulation reservoir for delivering pharmacological substances through an osmosis-based method with MSNs.
原文英語
頁(從 - 到)4790-4798
頁數9
期刊ACS Applied Materials and Interfaces
11
發行號5
DOIs
出版狀態已發佈 - 二月 6 2019

指紋

Silicon Dioxide
Silica
Nanoparticles
Blood
Encapsulation
Cells
Osmosis
Dialysis
Flow cytometry
Confocal microscopy
Drug delivery
Functional groups
Peptides
Electrostatics
Membrane Proteins
Hydrodynamics
Enzymes
Fluorescence
Proteins
Membranes

ASJC Scopus subject areas

  • Materials Science(all)

引用此文

Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes. / Chen, Zih An; Wu, Si Han; Chen, Peilin; Chen, Yi Ping; Mou, Chung Yuan.

於: ACS Applied Materials and Interfaces, 卷 11, 編號 5, 06.02.2019, p. 4790-4798.

研究成果: 雜誌貢獻文章

@article{3d58a6b5cf674ac2a3a440433e735a2a,
title = "Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes",
abstract = "Mesoporous silica nanoparticles (MSNs) hold great potential as a versatile platform for biomedical applications, especially drug delivery. However, evidence shows that MSNs even when PEGylated are rapidly cleared from the bloodstream by the monocyte phagocytic system. Erythrocytes, also called red blood cells (RBCs), can serve as biocompatible carriers of various bioactive substances, including drugs, enzymes, and peptides. In this work, we synthesize a series of fluorescent PEGylated MSNs with different synthetic diameters ranging from 10 to 200 nm and investigate the size effect on their encapsulation in human RBCs (hRBCs) by a hypotonic dialysis-based method. According to fluorescence images and flow cytometry analyses, we demonstrated that a hydrodynamic diameter below 30 nm is critical for efficient MSN encapsulation. Confocal microscopy and scanning electron microscopy images further confirmed that PEGylated MSNs were successfully embedded inside RBC. PEGylation serves an important role not only for stabilizing MSNs in biological milieu but also for reducing significant hemolysis caused by bare MSNs and thus for successful encapsulation. In addition to PEGylation, we further introduce positively charged functional groups onto the MSNs to show that nanoparticle-encapsulated hRBCs could serve as depots for delivering biological molecules through electrostatic attraction or chemical conjugation with MSNs. Also, we verify the existence of CD47 membrane protein, a marker of self, on the nanoparticle-encapsulated hRBCs and assess its ability of circulation in the blood, which could act as a circulation reservoir for delivering pharmacological substances through an osmosis-based method with MSNs.",
keywords = "hypotonic dialysis based method, mesoporous silica nanoparticles, PEGylated nanoparticle encapsulation, red blood cells",
author = "Chen, {Zih An} and Wu, {Si Han} and Peilin Chen and Chen, {Yi Ping} and Mou, {Chung Yuan}",
year = "2019",
month = "2",
day = "6",
doi = "10.1021/acsami.8b18434",
language = "English",
volume = "11",
pages = "4790--4798",
journal = "ACS applied materials & interfaces",
issn = "1944-8244",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Critical Features for Mesoporous Silica Nanoparticles Encapsulated into Erythrocytes

AU - Chen, Zih An

AU - Wu, Si Han

AU - Chen, Peilin

AU - Chen, Yi Ping

AU - Mou, Chung Yuan

PY - 2019/2/6

Y1 - 2019/2/6

N2 - Mesoporous silica nanoparticles (MSNs) hold great potential as a versatile platform for biomedical applications, especially drug delivery. However, evidence shows that MSNs even when PEGylated are rapidly cleared from the bloodstream by the monocyte phagocytic system. Erythrocytes, also called red blood cells (RBCs), can serve as biocompatible carriers of various bioactive substances, including drugs, enzymes, and peptides. In this work, we synthesize a series of fluorescent PEGylated MSNs with different synthetic diameters ranging from 10 to 200 nm and investigate the size effect on their encapsulation in human RBCs (hRBCs) by a hypotonic dialysis-based method. According to fluorescence images and flow cytometry analyses, we demonstrated that a hydrodynamic diameter below 30 nm is critical for efficient MSN encapsulation. Confocal microscopy and scanning electron microscopy images further confirmed that PEGylated MSNs were successfully embedded inside RBC. PEGylation serves an important role not only for stabilizing MSNs in biological milieu but also for reducing significant hemolysis caused by bare MSNs and thus for successful encapsulation. In addition to PEGylation, we further introduce positively charged functional groups onto the MSNs to show that nanoparticle-encapsulated hRBCs could serve as depots for delivering biological molecules through electrostatic attraction or chemical conjugation with MSNs. Also, we verify the existence of CD47 membrane protein, a marker of self, on the nanoparticle-encapsulated hRBCs and assess its ability of circulation in the blood, which could act as a circulation reservoir for delivering pharmacological substances through an osmosis-based method with MSNs.

AB - Mesoporous silica nanoparticles (MSNs) hold great potential as a versatile platform for biomedical applications, especially drug delivery. However, evidence shows that MSNs even when PEGylated are rapidly cleared from the bloodstream by the monocyte phagocytic system. Erythrocytes, also called red blood cells (RBCs), can serve as biocompatible carriers of various bioactive substances, including drugs, enzymes, and peptides. In this work, we synthesize a series of fluorescent PEGylated MSNs with different synthetic diameters ranging from 10 to 200 nm and investigate the size effect on their encapsulation in human RBCs (hRBCs) by a hypotonic dialysis-based method. According to fluorescence images and flow cytometry analyses, we demonstrated that a hydrodynamic diameter below 30 nm is critical for efficient MSN encapsulation. Confocal microscopy and scanning electron microscopy images further confirmed that PEGylated MSNs were successfully embedded inside RBC. PEGylation serves an important role not only for stabilizing MSNs in biological milieu but also for reducing significant hemolysis caused by bare MSNs and thus for successful encapsulation. In addition to PEGylation, we further introduce positively charged functional groups onto the MSNs to show that nanoparticle-encapsulated hRBCs could serve as depots for delivering biological molecules through electrostatic attraction or chemical conjugation with MSNs. Also, we verify the existence of CD47 membrane protein, a marker of self, on the nanoparticle-encapsulated hRBCs and assess its ability of circulation in the blood, which could act as a circulation reservoir for delivering pharmacological substances through an osmosis-based method with MSNs.

KW - hypotonic dialysis based method

KW - mesoporous silica nanoparticles

KW - PEGylated nanoparticle encapsulation

KW - red blood cells

UR - http://www.scopus.com/inward/record.url?scp=85060802151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060802151&partnerID=8YFLogxK

U2 - 10.1021/acsami.8b18434

DO - 10.1021/acsami.8b18434

M3 - Article

C2 - 30624037

AN - SCOPUS:85060802151

VL - 11

SP - 4790

EP - 4798

JO - ACS applied materials & interfaces

JF - ACS applied materials & interfaces

SN - 1944-8244

IS - 5

ER -